ArticleAnnals of medicine2025
Premenopausal women with pelvic organ prolapse and pelvic floor symptoms at a tertiary hospital in Thailand: a retrospective cohort study.
Article in Annals of medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Network-informed multi-trait genomic analysis decodes the shared genetic architecture and therapeutic landscape of pelvic floor disorders.npj aging · 2026Article
- The knowledge-symptom paradox in urinary incontinence: a health literacy and equity challenge in urban Southeast Asia.BMC public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimPelvic organ prolapse (POP) primarily affects older women, with limited data on premenopausal cases, especially among Asians. Severe pelvic floor symptoms, including urinary, bowel, and sexual dysfunction, remain understudied in this population. This study aimed to describe symptom severity and treatment outcomes in premenopausal POP patients.
methodsA retrospective cohort study was conducted on premenopausal POP patients at a university hospital over six years. The Pelvic Floor Bother Questionnaire (PFBQ) assessed symptom severity, and treatment outcomes were evaluated over two years. Data were presented as counts with percentages or means with standard deviations.
resultsAmong 87 women (mean age 44.8 ± 4.9 years), 12 (13.8%) had stage I, 47 (54.0%) stage II, 24 (27.7%) stage III, and 4 (4.6%) stage IV POP. Common comorbidities included dyslipidemia (13.8%), diabetes mellitus (11.5%), and thyroid disease (10.3%). Six patients had connective tissue diseases or nerve damage. Premenopausal women accounted for approximately 5.6% (87 out of 1,567) of all new POP cases in this population. The most bothersome symptoms were prolapse bulging (83.9%), urinary frequency (58.6%), and urgency (49.4%). Treatment included pelvic floor muscle training (10%), pessary use (28%), and surgery (62%). Vaginal hysterectomy with pelvic floor repair was most common, with 8 colpocleisis cases. Symptom improvement at two years was highest after surgery (90.1%), followed by pessary (82.6%) and pelvic floor training (68.3%).
conclusionThis study highlights the burden of POP and pelvic floor symptoms in Thai women, emphasizing the need for tailored management strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.